158 related articles for article (PubMed ID: 31350963)
1. Evaluating the Incidence Rate of an Accelerated Short Course High Dose Rate Intravaginal Brachytherapy Complications in Patients with Endometrial Cancer.
Amouzegar Hashemi F; Vesgari Kiasari Z; Kalaghchi B; Aghili M; Gholami S; Mansouri S; Moalej S; Maddah Safaei A
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2039-2043. PubMed ID: 31350963
[TBL] [Abstract][Full Text] [Related]
2. Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer.
Martínez-Monge R; Nagore G; Cambeiro M; Garrán C; Villafranca E; Jurado M
Brachytherapy; 2007; 6(3):195-200. PubMed ID: 17681240
[TBL] [Abstract][Full Text] [Related]
3. Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer.
Bahng AY; Dagan A; Bruner DW; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):667-73. PubMed ID: 21300451
[TBL] [Abstract][Full Text] [Related]
4. Late reactions after postoperative high-dose-rate intravaginal brachytherapy for endometrial cancer: a comparison of standardized and individualized target volumes.
Onsrud M; Strickert T; Marthinsen AB
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):749-55. PubMed ID: 11172958
[TBL] [Abstract][Full Text] [Related]
5. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
[TBL] [Abstract][Full Text] [Related]
6. Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.
Alektiar KM; McKee A; Venkatraman E; McKee B; Zelefsky MJ; Mychalczak BR; Hoskins WJ; Barakat RR
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):707-13. PubMed ID: 12062616
[TBL] [Abstract][Full Text] [Related]
7. Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma.
Park HS; Ratner ES; Lucarelli L; Polizzi S; Higgins SA; Damast S
Brachytherapy; 2015; 14(4):464-70. PubMed ID: 25887343
[TBL] [Abstract][Full Text] [Related]
8. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
Small W; Erickson B; Kwakwa F
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
[TBL] [Abstract][Full Text] [Related]
9. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
10. Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients.
Ríos I; Rovirosa A; Ascaso C; Valduvieco I; Herreros A; Castilla L; Sabater S; Holub K; Pahisa J; Biete A; Arenas M
Clin Transl Oncol; 2016 Sep; 18(9):925-30. PubMed ID: 26661111
[TBL] [Abstract][Full Text] [Related]
11. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
Ferrigno R; dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Gentil AC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1123-35. PubMed ID: 11483321
[TBL] [Abstract][Full Text] [Related]
12. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
13. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
14. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients.
Aydogan B; Mundt AJ; Smith BD; Mell LK; Wang S; Sutton H; Roeske JC
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):266-73. PubMed ID: 16618581
[TBL] [Abstract][Full Text] [Related]
15. Postoperative high dose-rate intravaginal brachytherapy combined with external irradiation for early stage endometrial cancer: a long-term follow-up.
Nori D; Merimsky O; Batata M; Caputo T
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):831-7. PubMed ID: 7960984
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of 1-week intravaginal high-dose-rate brachytherapy alone for endometrial cancer.
Gaztañaga M; Cambeiro M; Villafranca E; Vila M; Jurado M; Moreno M; Martínez-Monge R
Brachytherapy; 2012; 11(2):119-24. PubMed ID: 21684815
[TBL] [Abstract][Full Text] [Related]
17. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
Lee LJ; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
[TBL] [Abstract][Full Text] [Related]
18. A new method of anatomically conformal vaginal cuff HDR brachytherapy.
Miller DA; Richardson S; Grigsby PW
Gynecol Oncol; 2010 Mar; 116(3):413-8. PubMed ID: 19892389
[TBL] [Abstract][Full Text] [Related]
19. Postoperative vaginal cuff irradiation using high dose rate remote afterloading: a phase II clinical protocol.
Noyes WR; Bastin K; Edwards SA; Buchler DA; Stitt JA; Thomadsen BR; Fowler JF; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1439-43. PubMed ID: 7635785
[TBL] [Abstract][Full Text] [Related]
20. Three or four fractions of 4-5 Gy per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma.
Rovirosa A; Ascaso C; Sánchez-Reyes A; Herreros A; Abellana R; Pahisa J; Lejarcegui JA; Biete A
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):418-23. PubMed ID: 20800388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
